These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12901587)

  • 1. Current progress in enteropathogenic and enterohemorrhagic Escherichia coli vaccines.
    Horne C; Vallance BA; Deng W; Finlay BB
    Expert Rev Vaccines; 2002 Dec; 1(4):483-93. PubMed ID: 12901587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.
    Sanchez-Villamil JI; Tapia D; Torres AG
    mBio; 2019 Aug; 10(4):. PubMed ID: 31409688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of recombinant porcine attaching and effacing-associated protein compared with intimin fragment in Escherichia coli O157:H7-infected mice.
    Li T; Han R; Wang Q; Wang S; Fang H; Li Z; Tu W; Wang D; Wang H
    Foodborne Pathog Dis; 2013 Dec; 10(12):1016-22. PubMed ID: 24093308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross reactivity of enterohemorrhagic Escherichia coli O157:H7-specific sera with non-O157 serotypes.
    Asper DJ; Sekirov I; Finlay BB; Rogan D; Potter AA
    Vaccine; 2007 Nov; 25(49):8262-9. PubMed ID: 17980466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteropathogenic and enterohemorrhagic Escherichia coli infections: emerging themes in pathogenesis and prevention.
    Vallance BA; Chan C; Robertson ML; Finlay BB
    Can J Gastroenterol; 2002 Nov; 16(11):771-8. PubMed ID: 12464970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins.
    Liu J; Sun Y; Feng S; Zhu L; Guo X; Qi C
    Vaccine; 2009 Oct; 27(43):5929-35. PubMed ID: 19682616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterohemorrhagic Escherichia coli O157:H7: case report.
    Erdoğan H; Erdoğan A; Levent B; Kayali R; Arslan H
    Turk J Pediatr; 2008; 50(5):488-91. PubMed ID: 19102057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome.
    Goldwater PN
    Expert Rev Anti Infect Ther; 2007 Aug; 5(4):653-63. PubMed ID: 17678428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice.
    Babiuk S; Asper DJ; Rogan D; Mutwiri GK; Potter AA
    Microb Pathog; 2008 Jul; 45(1):7-11. PubMed ID: 18487034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Escherichia coli O157:H7 siderophore receptor/porin proteins-based vaccine in feedlot cattle naturally shedding E. coli O157.
    Fox JT; Thomson DU; Drouillard JS; Thornton AB; Burkhardt DT; Emery DA; Nagaraja TG
    Foodborne Pathog Dis; 2009 Sep; 6(7):893-9. PubMed ID: 19737065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
    Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
    Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of lipid A deacylase as a novel, highly conserved and protective antigen against enterohemorrhagic Escherichia coli.
    Rojas-Lopez M; Martinelli M; Brandi V; Jubelin G; Polticelli F; Soriani M; Pizza M; Desvaux M; Rosini R
    Sci Rep; 2019 Nov; 9(1):17014. PubMed ID: 31745113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine innate and adaptive immune responses against Escherichia coli O157:H7 and vaccination strategies to reduce faecal shedding in ruminants.
    Vande Walle K; Vanrompay D; Cox E
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):109-20. PubMed ID: 23084625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome.
    Ludwig K; Bitzan M; Bobrowski C; Müller-Wiefel DE
    J Infect Dis; 2002 Aug; 186(4):566-9. PubMed ID: 12195387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-dose regimen of a vaccine against Escherichia coli O157:H7 type III secreted proteins reduced environmental transmission of the agent in a large-scale commercial beef feedlot clinical trial.
    Smith DR; Moxley RA; Peterson RE; Klopfenstein TJ; Erickson GE; Clowser SL
    Foodborne Pathog Dis; 2008 Oct; 5(5):589-98. PubMed ID: 18681791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections.
    Serna A; Boedeker EC
    Curr Opin Gastroenterol; 2008 Jan; 24(1):38-47. PubMed ID: 18043231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotype-specific antibody responses against Escherichia coli O157:H7 locus of enterocyte effacement proteins in adult beef cattle following experimental infection.
    Bretschneider G; Berberov EM; Moxley RA
    Vet Immunol Immunopathol; 2007 Aug; 118(3-4):229-38. PubMed ID: 17617472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines for enterotoxigenic Escherichia coli: current status.
    Boedeker EC
    Curr Opin Gastroenterol; 2005 Jan; 21(1):15-9. PubMed ID: 15687879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-dose regimen of a vaccine against type III secreted proteins reduced Escherichia coli O157:H7 colonization of the terminal rectum in beef cattle in commercial feedlots.
    Smith DR; Moxley RA; Peterson RE; Klopfenstein TJ; Erickson GE; Bretschneider G; Berberov EM; Clowser S
    Foodborne Pathog Dis; 2009 Mar; 6(2):155-61. PubMed ID: 19105625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against enterotoxigenic Escherichia coli.
    Svennerholm AM; Tobias J
    Expert Rev Vaccines; 2008 Aug; 7(6):795-804. PubMed ID: 18665777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.